Association of busulfan area under the curve with veno-occlusive disease following BMT.
S P Dix(Emory University Hospital), Rein Saral(University of Maryland, Baltimore), C D Hillyer, Terri G Davidson, C. Gilmore, I Jerkunica, John R. Wingard(Radboud University Nijmegen), L Lin, Leonard T. Heffner, H. Kent Holland(Sheba Medical Center), E. Winton(Emory University), S M Devine, Robert B. Geller, Roger York, Richard E. Mullins
PubMed
February 1, 1996
Cited by 323
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k